Different mRNA and Protein Expression of Matrix Metalloproteinases 2 and 9 and Tissue Inhibitor of Metalloproteinases 1 in Benign and Malignant Prostate Tissue
- 1 October 2002
- journal article
- Published by Elsevier in European Urology
- Vol. 42 (4) , 398-406
- https://doi.org/10.1016/s0302-2838(02)00324-x
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Matrix metalloproteinases (MMPs) in fresh human prostate tumour tissue and organ-cultured prostate tissue: Levels of collagenolytic and gelatinolytic MMPs are low, variable and different in fresh tissue versus organ-cultured tissueBritish Journal of Cancer, 2001
- Osteoblast-derived TGF-β1 modulates matrix degrading protease expression and activity in prostate cancer cellsInternational Journal of Cancer, 2000
- Quantification of matrix metalloproteinases and tissue inhibitors of metalloproteinase in prostatic tissue: Analytical aspectsThe Prostate, 1998
- Factors influencing the ratio of free to total prostate-specific antigen in serumInternational Journal of Cancer, 1997
- In situ hybridization studies of metalloproteinases 2 and 9 and TIMP-1 and TIMP-2 expression in human prostate cancerClinical & Experimental Metastasis, 1997
- Increased matrix metalloproteinase-9 secretion in short-term tissue cultures of prostatic tumor cellsInternational Journal of Cancer, 1996
- Mechanisms Controlling the Transcription of Matrix Metalloproteinase Genes in Normal and Neoplastic CellsEnzyme and Protein, 1996
- Matrix metalloproteinase 9 expression in primary human prostatic adenocarcinoma and benign prostatic hyperplasiaBritish Journal of Cancer, 1994
- Characterization of Gelatin‐Degrading Metalloproteinase Activities of the Dunning Rat Prostate Tumor Grown in Nude MiceThe Prostate, 1991
- Collagenase activity in cultures of rat prostate carcinomaBiochimica et Biophysica Acta (BBA) - Enzymology, 1979